Liposomes are well-known nanoparticles with a non-toxic nature and the ability to
incorporate both hydrophilic and hydrophobic drugs simultaneously. As modern drug …

In the development of cancer chemotherapy, besides the discovery of new anticancer drugs,
a variety of nanocarrier systems for the delivery of previously developed and new …

The delivery of chemotherapeutics to solid tumors using smart drug delivery systems
(SDDSs) takes advantage of the unique physiology of tumors (ie, disordered structure, leaky …

Published literature on cancer by health agencies and health organizations reveals
increased cancer incidence year by year. The first line of cancer treatment involves one or …

Site-specific delivery of the therapeutic agents to the target site is the most challenging and
most important goal from the clinical point of view. Recently, much effort has been indulged …

In the advancement of tumor therapy, in addition to the search for new antitumor
compounds, the development of nano-drug delivery systems has opened up new pathways …

The limitations of conventional cancer treatment are driving the emergence and
development of nanomedicines. Research in liposomal nanomedicine for cancer therapy is …

Cancer is a broad term used to describe a group of diseases that have more than 270 types.
Today, due to the suffering of patients from the side effects of existing methods in the …

Liposomes are biodegradable and biocompatible lipid bilayer vesicles which are widely
exploited as preferred carriers for smart delivery of both hydrophobic as well as hydrophilic …

Since more than 40 years liposomes have being extensively studied for their potential as
carriers of anticancer drugs. The basic principle behind their use for cancer treatment …